Pharmaceutical Company
Fiscal year 2022 LHHS appropriations report language on Wilson's Disease, Myasthenia Gravis; 
Neuromyelitis Optica Spectrum Disorder (NMOSD);
Low volume DRG payments for rare disease therapies and Home Infusion. Low volume DRG payments for rare disease therapies. FDA - rare and orphan disease issues; 
Prescription drug coverage and payment policies; 
Medical innovation issues.
BUD - Budget/Appropriations MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
NVG, LLC
1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US
LISA GERMAN FOSTER LISA GERMAN FOSTER ANDREA LARUE LISA GERMAN FOSTER